Novartis offloads failed cancer drug to Oncology Venture | Fierce Biotech
Novartis, Propeller Health co-package new asthma treatment | MobiHealthNews
Inclisiran Reduced LDL-C in Obese Patients | DAIC
Retina/Vitreous Age-related Macular Degeneration
Google, Mayo Clinic team up on patient data and AI healthcare research | Fierce Biotech
Poster II, 2012
Emirates Dermatology Society And Novartis Launch 'Skin To Live In' A Groundbreaking Campaign For People Living With Psoriasis - Health Magazine
Announcements | The Mayo Laboratory
Novartis taps Ada Health's AI diagnosis platform for tracking rare, immunological conditions | Fierce Biotech
Can data from a heart disease trial lead to a potential cancer treatment? | Novartis
Asthma biologics
Doing It The Nike Way – Novartis, AstraZeneca On Making The Metaverse Work :: Scrip
Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy | Science Advances
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase | Journal of Medicinal Chemistry
Novartis Australia HQ Building by HDR - Architizer
New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17 regardless of age and gender
Systane ULTRA Lubricant Eye Drops Soothes Irritated Dry Eye Symptom Relief 30 mL 56394102400 | eBay
Bayer acquires AskBio; Novartis' Iptacopan; Forma's AML Therapy
Novartis Pharmaceuticals NPS & Customer Reviews | Comparably
Novartis punts NASH prospect amid pipeline prioritization pivot
Sickle cell cure will be cost-effective if health disparities considered -study finds | Reuters
Cancer Treatment May Inhibit Immune Response to COVID-19 Vaccination - Specialty Pharmacy Continuum
